Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2718-2725

  Partridge, Max ^a   Li, Shu Rui ^a   Pateromichelakis, Stelios ^a   Francis, Rebecca ^a   Phillips, E ^a   Huang, Xiao Hong ^a   Tesfa Selase, Fis ^a   Langdon, John D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; METASTASIS; MOUTH CANCER; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0033939967     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Franceschi, D., Gupta, R., Spiro, R. H., and Shah, J. P. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am. J. Surg., 166: 360-365, 1993.
2. Vikram, B., Strong, E. W., Shah, J. P., and Spiro, R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg., 6: 730-733, 1984.
3. Goepfert, H. Are we making any progress? Commentary. Arch. Otolaryngol., 110: 562-563, 1984.
4. Papac, R. J. Distant metastases from head and neck cancer. Cancer (Phila.), 53: 342-345, 1984.
5. Zbaren, P., and Lehmann, W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 113: 762-764, 1987.
6. Leemans, C. R., Tiwari, R., Nauta, J. J. P., van der Waal, I., and Snow, G. B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer (Phila.), 71: 452-456, 1993.
7. Fardy, M. J., and Langdon, J. D. The changing pattern of oral cancer 1977-1995. Br. J. Oral Maxillofac. Surg., 33: 328, 1995.
8. Slootweg, P. J., Hordijk, G. J., and Koole, R. Autopsy findings in patients with head and neck squamous cell cancer and their therapeutic relevance. Oral Oncol. Eur. J. Cancer, 32B: 413-415, 1996.
9. Looser, K. G., Shah, J. P., and Strong, E. W. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg., 1: 107-111, 1978.
10. Loree, T. R., and Strong, E. W. Significance of positive margins in oral cavity squamous carcinoma. Am. J. Surg., 160: 110-114, 1990.
11. Cook, J. A., Jones, A. S., Phillips, D. E., and Soler Lluch, E. Implications of tumour in resection margins following surgical treatment for squamous cell carcinoma of the head and neck. Clin. Otol., 18: 37-41, 1993.
12. Jones, A. S., Bin Hanafi, Z., Nadapalan, V., Roland, N. J., Kinsella, A., and Helliwell, T. R. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br. J. Cancer, 74: 128-132, 1996.
13. Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., and Sidransky, D. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 429-435, 1995.
14. Davidoff, A. M., Kerns, B-J. M., Inglehart, J. D., and Marks, J. Genetic basis for p53 overexpression in human breast cancer. Proc. Natl. Acad. Sci. USA, 53: 4189-4196, 1993.
15. Sameshina, Y., Matsuno, Y., and Hirohashi, S. Alterations of the p53 gene are common and critical events for the maintenance of the malignant phenotypes in small-cell lung carcinoma. Oncogene, 7: 451-457, 1992.
16. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
17. Burns, J. E., McFarlane, R., and Clark, L. J. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. Oral Oncol. Eur. J. Cancer, 30B: 335-337, 1994.
18. Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold-Mende, C., Schuhmann, A., and Bosch, F. X. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res., 53: 4189-4196, 1993.
19. Chung, K. Y., Mukhopadhyay, T., Kim, J., Casson, A., Ro, J. Y., Goepfert, H., Hong, W. K., and Roth, J. A. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res., 53: 1676-1683, 1993.
20. Gallo, O., and Bianchi, S. p53 expression: a potential biomarker for risk of multiple primary malignancies in the upper aerodigestive tract. Oral Oncol. Eur. J. Cancer, 31B: 53-57, 1995.
21. Kanjilal, S., Strom, S. S., Clayman, G. L., Weber, R. S., El-Naggar, A. K., Kapur, V., Cummings, K. K., Hill, L. A., Spitz, M. R., Kripke, M. L., and Ananthaswamy, H. N. p53 mutations in non-melanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res., 55: 3604-3609, 1995.
22. Wandel, F., Estreicher, A., Bron, L., Flaman, J-M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene, 14: 163-169, 1997.
23. Flaman, J. M., Frebourg, T., Moreau, V., Charbonnier, F., Martin, C., Chappuis, P., Sappino, A. P., Limacher, J. M., Bron, L., Benhattar, J., Tada, M., van Meir, E. G., Estreicher, A., and Iggo, R. D. A simple p53 functional assay for screening cell lines, blood and tumours. Proc. Natl. Acad. Sci. USA, 92: 3963-3967, 1995.
24. Wollenberg, B., Ollesch, A., Maag, K., Funke, I., and Wilmes, E. Micrometastases in bone marrow of patients with squamous cell carcinoma of the head and neck. Laryngol. Rhinol. Otol., 73: 88-93, 1994.
25. Gath, H. J., Heissler, E., Hell, B., Bier, J., Riethmuller, G., and Pantel, K. Immunocytologic detection of isolated tumour cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. Int. J. Oral Maxillofac. Surg., 24: 351-355, 1995.
26. Partridge, M., Phillips, E., Francis, R., and Li, S-R. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. J. Pathol., 189: 368-377, 1999.
27. Tada, M., Iggo, R. D., Ishii, N., Shinohe, Y., Sakuma, S., Estreicher, A., Sawamura, Y., and Abe, H. Clonality and stability of the p53 gene in human astrocytic tumour cells: quantitative analysis of p53 gene mutations by yeast functional assay. Int. J. Cancer, 67: 447-450, 1996.
28. Partridge, M. Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Ann. R. Coll. Surg. Engl., 81: 1-11, 1999.
29. Partridge, M., and Warnakulasuriya, K. A. A. S. The biology of cancer. In: P. Ward Booth, J-E. Hauseman, and S. Schendel (eds.), Maxillofacial Surgery, pp. 309-324. London: Churchill Livingstone, 1999.
30. Lowe, S., Ruley, H., Jacks, T., and Housman, D. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
31. Snow, G. B. Evaluation and staging of the patient with head and neck cancer. In: E. N. Myers and J. Y. Suen (eds.), Cancer of the Head and Neck, Ed. 2, pp. 17-38. New York: Churchill Livingstone, 1989.
32. Lee, J. G. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: a study of surgical margins. Trans. Am. Acad. Ophthalmol. Otolaryngol., 78: 49-53, 1974.
33. Jesse, R. H., and Sugarbaker, E. V. Squamous cell carcinoma of the oropharynx: why we fail. Am. J. Surg., 132: 435-438, 1976.
34. Scholl, P., Byers, R. M., Batsakis, J. G., Wolf, P., and Santini, H. Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue: prognostic and therapeutic implications. Am. J. Surg., 152: 354-360, 1986.
35. Zieske, L. A., Johnson, J. T., Myers, E. N., and Thearle, P. B. Squamous cell carcinoma with positive margins: surgery and postoperative irradiation. Arch. Otolaryngol. Head Neck Surg., 112: 863-866, 1986.
36. Feinmesser, R., Freeman, J. L., Feinmesser, M., Noyek, A., and Mullen, J. B. Role of modern imaging in decision-making for elective neck dissection. Head Neck, 14: 173-176, 1992.
37. Subin, L. H., and Wittekind, C. H. (eds.), International Union Against Cancer. The TNM classification of Malignant Tumours, Ed. 5, pp. 20-24. New York: John Wiley & Sons, Inc., 1977.
38. Shah, J. P., Candela, F. D., and Poddar, A. K. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer (Phila.), 66: 109-113, 1990.
39. Brown, D. C., Purushotham, A. D., and Birnie, G. D. Detection of intraoperative tumour cell dissemination in patients with breast cancer by use of reverse transcription and polymerase chain reaction. Surgery, 117: 96-101, 1995.